volume 27, issue 3, P477-482 2011
DOI: 10.3233/jad-2011-110650
View full text
|
Sign up to set email alerts
|
Share

Abstract: Alzheimer's disease (AD) is multi-factorial mental disorder characterized by a copious array of congruent features cumulating in disrupted memory and dysthymia. Though the mechanism remains elusive, the highly unspecific pharmaceutical, memantine, provides modest benefits for patients with moderate-to-severe AD. A greater understanding of how memantine affects cognitive function promises to facilitate the search for better therapeutics. We therefore examined cognitive flexibility of mice following 5 and 10 mg/…

Expand abstract

Search citation statements

Order By: Relevance

Citation Types

2
7
0

Paper Sections

0
0
0
0
0

Publication Types

0
0
0
0

Relationship

0
0

Authors

Journals